Isotope R&D and Production (DOE IP) Office Hours

Past Office Hours

Monday, August 12, 2024, at 2pm ET – How to Become a Reviewer for DOE IP.

Monday, July 8, 2024, at 2pm ET – The FOA Application and Review Process. (Slides | Video)

Monday, June 10, 2024 – Stable Isotope Portfolio. (Slides | Video)

Monday, May 13, 2024 – Working with a Program Manager Before, During, and After an Award. (Slides | Video)

Monday, April 8, 2024 – Competitive DOE IP Funding Opportunities for R&D and Training. (Slides | Video)

Monday, March 11, 2024 – Introduction to the DOE Isotope Program and Mission. (Slides | Video)

Highlights

View all Highlights

Images showing mice injected with radioactive antimony. Left panel with TREN-CAM shows how the radioactive antimony will be active longer in the treatment areas. The right panel shows that the antimony without TREN-CAM doesn’t stay in the desired areas.

Progress Towards Unlocking Antimony’s Cancer Treatment Potential

Researchers gain a new understanding of the binding chemistry of radioactive antimony, opening doors for targeted therapy.

Steps in terbium-161 (Tb-161) production. The University of Utah TRIGA reactor induces thermal neutron capture on gadolinium-160 (Gd-160), which decays to Tb-161. Separating the Gd-160 target yields high-purity Tb-161 for cancer therapy and diagnosis.

To Advance Cancer Therapy, University Starts Producing Terbium-161

A University of Utah research team demonstrates that a low power university research reactor can produce terbium-161 at high purity from gadolinium-160.

Contact

Address Office of Isotope R&D and Production, IRP
U.S. Department of Energy
1000 Independence Avenue, SW
Washington, D.C. 20585-1290

Phone Tel (301) 903-3400

Email Send us a message Isotopes@science.doe.gov